» Articles » PMID: 28937587

µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2017 Sep 23
PMID 28937587
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The Conus genus includes around 500 species of marine mollusks with a peculiar production of venomous peptides known as conotoxins (CTX). Each species is able to produce up to 200 different biological active peptides. Common structure of CTX is the low number of amino acids stabilized by disulfide bridges and post-translational modifications that give rise to different isoforms. µ and µO-CTX are two isoforms that specifically target voltage-gated sodium channels. These, by inducing the entrance of sodium ions in the cell, modulate the neuronal excitability by depolarizing plasma membrane and propagating the action potential. Hyperexcitability and mutations of sodium channels are responsible for perception and transmission of inflammatory and neuropathic pain states. In this review, we describe the current knowledge of µ-CTX interacting with the different sodium channels subtypes, the mechanism of action and their potential therapeutic use as analgesic compounds in the clinical management of pain conditions.

Citing Articles

In Silico Conotoxin Studies: Progress and Prospects.

Li R, Hasan M, Wang D Molecules. 2025; 29(24.

PMID: 39770149 PMC: 11677113. DOI: 10.3390/molecules29246061.


Chemical Synthesis and Insecticidal Activity Research Based on α-Conotoxins.

Lin C, Qin H, Liao Y, Chen J, Gao B Molecules. 2024; 29(12).

PMID: 38930912 PMC: 11206848. DOI: 10.3390/molecules29122846.


Voltage-Gated Sodium Channel Inhibition by µ-Conotoxins.

McMahon K, Vetter I, Schroeder C Toxins (Basel). 2024; 16(1).

PMID: 38251271 PMC: 10819908. DOI: 10.3390/toxins16010055.


Neuronomodulation of Excitable Neurons.

Chen Y, Xiao L, Qiu J Neurosci Bull. 2023; 40(1):103-112.

PMID: 37584858 PMC: 10774251. DOI: 10.1007/s12264-023-01095-w.


Historical Perspective of the Characterization of Conotoxins Targeting Voltage-Gated Sodium Channels.

Groome J Mar Drugs. 2023; 21(4).

PMID: 37103349 PMC: 10142487. DOI: 10.3390/md21040209.


References
1.
Fertleman C, Baker M, Parker K, Moffatt S, Elmslie F, Abrahamsen B . SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006; 52(5):767-74. DOI: 10.1016/j.neuron.2006.10.006. View

2.
Chen R, Robinson A, Chung S . Mechanism of μ-conotoxin PIIIA binding to the voltage-gated Na+ channel NaV1.4. PLoS One. 2014; 9(3):e93267. PMC: 3968119. DOI: 10.1371/journal.pone.0093267. View

3.
Kim J . Channelopathies. Korean J Pediatr. 2014; 57(1):1-18. PMC: 3935107. DOI: 10.3345/kjp.2014.57.1.1. View

4.
Dib-Hajj S, Cummins T, Black J, Waxman S . From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci. 2007; 30(11):555-63. DOI: 10.1016/j.tins.2007.08.004. View

5.
Huang W, Liu M, Yan S, Yan N . Structure-based assessment of disease-related mutations in human voltage-gated sodium channels. Protein Cell. 2017; 8(6):401-438. PMC: 5445024. DOI: 10.1007/s13238-017-0372-z. View